Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06690957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 3v3
  2. Primary completion date: Oct 1, 2024 to Oct 1, 2027
    • Start date: Oct 1, 2024 to Feb 1, 2019
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the potential usefulness of 68Ga/18F-TATE/JR11/LM3 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various SSTR-related disease patients.
Trial Details
NCT Number NCT06690957
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions
(from sponsor)		 SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Related terms Neoplasm Metastasis, Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov